Inferior olive serotonin and norepinephrine levels during development in the genetically dystonie rat

Mark Ledoux, Joan F. Lorden, Jeff M. Ervin

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

The dystonic (dt) rat is an autosomal recessive mutant with a motor syndrome that shares several features with idiopathic torsion dystonia in humans. In the dt rats, marked biochemical and physiological abnormalities have been localized to the olivo-cerebellar system. At the pharmacological level, the dt rats exhibit enhanced sensitivity to the behavioral effects of serotonergic (5HT) agonists, including quipazine, a drug that activates the neurons of the inferior olive (IO). High performance liquid chromatography with electrochemical detection was used to assay 5-HT, 5-hydroxyindoleacetic acid (5HIAA), and norepinephrine (NE) in micropunches of the IO in normal and dt rats at 14, 18 and 22 days of age. Samples of the rostral frontal lobes were used as internal controls. Significant age-dependent effects were seen on 5-HT and 5-HIAA levels in the IO, but not the frontal cortex, in both groups. Although both groups reached similar 5-HT levels by postnatal day 22, a significant interaction effect between age and phenotype indicated a difference in the pattern of development. Administration of quipazine (10 mg/kg, IP) to 18-day-old normal and dt rats l h prior to sacrifice caused significant reductions in NE, 5-HIAA and the ratio of 5-HIAA to 5-HT; however, no phenotypic differences were detected. The findings do not suggest that the differential behavioral responses to 5-HT agonists seen in normal and dt rats are the result of global abnormalities in 5-HT systems, nor do they suggest the presence of presynaptic defects in the IO. The age-dependent differences in 5-HT levels in the IO may, however, indicate a developmental abnormality in the 5-HT innervation of this structure in the dt rat. Serotonin Norepinephrine Inferior olive Dystonia 5-hydroxyindoleacetic acid Quipazine.

Original languageEnglish (US)
Pages (from-to)299-305
Number of pages7
JournalBrain Research Bulletin
Volume33
Issue number3
DOIs
StatePublished - Jan 1 1994

Fingerprint

Serotonin
Norepinephrine
Hydroxyindoleacetic Acid
Quipazine
Serotonin Receptor Agonists
Frontal Lobe
Dystonia Musculorum Deformans
High Pressure Liquid Chromatography
Pharmacology
Phenotype
Neurons
Pharmaceutical Preparations

All Science Journal Classification (ASJC) codes

  • Neuroscience(all)

Cite this

Inferior olive serotonin and norepinephrine levels during development in the genetically dystonie rat. / Ledoux, Mark; Lorden, Joan F.; Ervin, Jeff M.

In: Brain Research Bulletin, Vol. 33, No. 3, 01.01.1994, p. 299-305.

Research output: Contribution to journalArticle

Ledoux, Mark ; Lorden, Joan F. ; Ervin, Jeff M. / Inferior olive serotonin and norepinephrine levels during development in the genetically dystonie rat. In: Brain Research Bulletin. 1994 ; Vol. 33, No. 3. pp. 299-305.
@article{1e238a657fb0410aba1b4757144545c0,
title = "Inferior olive serotonin and norepinephrine levels during development in the genetically dystonie rat",
abstract = "The dystonic (dt) rat is an autosomal recessive mutant with a motor syndrome that shares several features with idiopathic torsion dystonia in humans. In the dt rats, marked biochemical and physiological abnormalities have been localized to the olivo-cerebellar system. At the pharmacological level, the dt rats exhibit enhanced sensitivity to the behavioral effects of serotonergic (5HT) agonists, including quipazine, a drug that activates the neurons of the inferior olive (IO). High performance liquid chromatography with electrochemical detection was used to assay 5-HT, 5-hydroxyindoleacetic acid (5HIAA), and norepinephrine (NE) in micropunches of the IO in normal and dt rats at 14, 18 and 22 days of age. Samples of the rostral frontal lobes were used as internal controls. Significant age-dependent effects were seen on 5-HT and 5-HIAA levels in the IO, but not the frontal cortex, in both groups. Although both groups reached similar 5-HT levels by postnatal day 22, a significant interaction effect between age and phenotype indicated a difference in the pattern of development. Administration of quipazine (10 mg/kg, IP) to 18-day-old normal and dt rats l h prior to sacrifice caused significant reductions in NE, 5-HIAA and the ratio of 5-HIAA to 5-HT; however, no phenotypic differences were detected. The findings do not suggest that the differential behavioral responses to 5-HT agonists seen in normal and dt rats are the result of global abnormalities in 5-HT systems, nor do they suggest the presence of presynaptic defects in the IO. The age-dependent differences in 5-HT levels in the IO may, however, indicate a developmental abnormality in the 5-HT innervation of this structure in the dt rat. Serotonin Norepinephrine Inferior olive Dystonia 5-hydroxyindoleacetic acid Quipazine.",
author = "Mark Ledoux and Lorden, {Joan F.} and Ervin, {Jeff M.}",
year = "1994",
month = "1",
day = "1",
doi = "10.1016/0361-9230(94)90197-X",
language = "English (US)",
volume = "33",
pages = "299--305",
journal = "Brain Research Bulletin",
issn = "0361-9230",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Inferior olive serotonin and norepinephrine levels during development in the genetically dystonie rat

AU - Ledoux, Mark

AU - Lorden, Joan F.

AU - Ervin, Jeff M.

PY - 1994/1/1

Y1 - 1994/1/1

N2 - The dystonic (dt) rat is an autosomal recessive mutant with a motor syndrome that shares several features with idiopathic torsion dystonia in humans. In the dt rats, marked biochemical and physiological abnormalities have been localized to the olivo-cerebellar system. At the pharmacological level, the dt rats exhibit enhanced sensitivity to the behavioral effects of serotonergic (5HT) agonists, including quipazine, a drug that activates the neurons of the inferior olive (IO). High performance liquid chromatography with electrochemical detection was used to assay 5-HT, 5-hydroxyindoleacetic acid (5HIAA), and norepinephrine (NE) in micropunches of the IO in normal and dt rats at 14, 18 and 22 days of age. Samples of the rostral frontal lobes were used as internal controls. Significant age-dependent effects were seen on 5-HT and 5-HIAA levels in the IO, but not the frontal cortex, in both groups. Although both groups reached similar 5-HT levels by postnatal day 22, a significant interaction effect between age and phenotype indicated a difference in the pattern of development. Administration of quipazine (10 mg/kg, IP) to 18-day-old normal and dt rats l h prior to sacrifice caused significant reductions in NE, 5-HIAA and the ratio of 5-HIAA to 5-HT; however, no phenotypic differences were detected. The findings do not suggest that the differential behavioral responses to 5-HT agonists seen in normal and dt rats are the result of global abnormalities in 5-HT systems, nor do they suggest the presence of presynaptic defects in the IO. The age-dependent differences in 5-HT levels in the IO may, however, indicate a developmental abnormality in the 5-HT innervation of this structure in the dt rat. Serotonin Norepinephrine Inferior olive Dystonia 5-hydroxyindoleacetic acid Quipazine.

AB - The dystonic (dt) rat is an autosomal recessive mutant with a motor syndrome that shares several features with idiopathic torsion dystonia in humans. In the dt rats, marked biochemical and physiological abnormalities have been localized to the olivo-cerebellar system. At the pharmacological level, the dt rats exhibit enhanced sensitivity to the behavioral effects of serotonergic (5HT) agonists, including quipazine, a drug that activates the neurons of the inferior olive (IO). High performance liquid chromatography with electrochemical detection was used to assay 5-HT, 5-hydroxyindoleacetic acid (5HIAA), and norepinephrine (NE) in micropunches of the IO in normal and dt rats at 14, 18 and 22 days of age. Samples of the rostral frontal lobes were used as internal controls. Significant age-dependent effects were seen on 5-HT and 5-HIAA levels in the IO, but not the frontal cortex, in both groups. Although both groups reached similar 5-HT levels by postnatal day 22, a significant interaction effect between age and phenotype indicated a difference in the pattern of development. Administration of quipazine (10 mg/kg, IP) to 18-day-old normal and dt rats l h prior to sacrifice caused significant reductions in NE, 5-HIAA and the ratio of 5-HIAA to 5-HT; however, no phenotypic differences were detected. The findings do not suggest that the differential behavioral responses to 5-HT agonists seen in normal and dt rats are the result of global abnormalities in 5-HT systems, nor do they suggest the presence of presynaptic defects in the IO. The age-dependent differences in 5-HT levels in the IO may, however, indicate a developmental abnormality in the 5-HT innervation of this structure in the dt rat. Serotonin Norepinephrine Inferior olive Dystonia 5-hydroxyindoleacetic acid Quipazine.

UR - http://www.scopus.com/inward/record.url?scp=0028366425&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028366425&partnerID=8YFLogxK

U2 - 10.1016/0361-9230(94)90197-X

DO - 10.1016/0361-9230(94)90197-X

M3 - Article

C2 - 7507398

AN - SCOPUS:0028366425

VL - 33

SP - 299

EP - 305

JO - Brain Research Bulletin

JF - Brain Research Bulletin

SN - 0361-9230

IS - 3

ER -